Advertisement
News
Advertisement

Cardiogenesis Corporation to Report 2010 Third Quarter Results on November 3rd

Wed, 10/20/2010 - 4:32am
Bio-Medicine.Org

IRVINE, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (OTCQB: CGCP) announced that the company will release results for its third quarter ended September 30, 2010 on Wednesday, November 3, 2010.  The company added that Paul J. McCormick, its Executive Chairman, and William R. Abbott, its Senior Vice President and Chief Financial Officer, will host an investor conference call that day at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) to review the company's financial results and business outlook.

The call is open to all interested investors through a live audio broadcast via the Internet at www.cardiogenesis.com.  The call also will be available to investors and analysts by dialing (866) 783-2145 within the U.S. and Canada and (857) 350-1604 from abroad.  The passcode is 25300206.

The webcast will be archived on the company's web site and will be available for playback for seven days beginning shortly after the live webcast.  A telephonic playback of the conference call will be available beginning at 8:00 p.m. Eastern time on Wednesday, November 3, 2010, and continue through 8:00 p.m. Eastern time on Wednesday, November 10, 2010.  The replay can be accessed by calling (888) 286-8010 within the U.S. and Canada and (617) 801-6888 from abroad.  The replay passcode is 55199188.

About Cardiogenesis Corporation

Cardiogenesis is a medical device company specializing in the treatment of cardiovascular disease and is a leader in devices that stimulate cardiac angiogenesis.  The company's market leading Holmium:YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina.  Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been sh

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading